Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

2-(cyclohexylmethyl)-Plumbagin is a derivative of the naphthoquinone plumbagin (Item No. 14314).1 It is selectively cytotoxic to PANC-1 human pancreatic cancer cells under nutrient-deprived conditions, which mimic the microenvironment of pancreatic cancer tumors, over PANC-1 cells under nutrient-rich conditions with 50% preferential cytotoxicity values (PC50s) of 0.11 and 47.2 µM, respectively. It also induces apoptosis in PANC-1 cells when used at a concentration of 1 µM. 2-(cyclohexylmethyl)-Plumbagin also selectively reduces phosphorylation of Akt and mammalian target of rapamycin (mTOR) in PANC-1 cells under nutrient-deprived, but not nutrient-rich, conditions. It reduces tumor volume and weight in a MiaPaCa-2 pancreatic cancer mouse xenograft model when administered at doses of 50 and 250 µg/animal five times per week.
WARNING This product is not for human or veterinary use.
1. Targeting pancreatic cancer with novel plumbagin derivatives: Design, synthesis, molecular mechanism, in vitro and in vivo evaluation. J. Med. Chem. 66(12), 8054-8065 (2023).